Suppression of angiogenesis and tumour progression by combretastatin and derivatives.
Sign Up to like & getrecommendations! Published in 2017 at "Cancer letters"
DOI: 10.1016/j.canlet.2017.06.032
Abstract: The search for small molecule inhibitors has gained prominence with the recognition of their inherent advantage for cancer therapy. Combretastatin is a naturally occurring small stilbenoid. By virtue of the ability to bind to tubulin… read more here.
Keywords: angiogenesis tumour; suppression angiogenesis; combretastatin derivatives; tumour progression ... See more keywords